搜尋結果
Council Post: The Philanthropic Choice Between Innovation And Stagnation
Forbes· 3 日前Philanthropy was built backward—it started with creating systems, strategies and outcomes ...
Australia to ban knock-offs of popular weight-loss drugs Ozempic, Mounjaro
Reuters· 3 日前Australia said on Wednesday it will ban copies of drugs used for weight loss such as Ozempic and Mounjaro, arguing that ...
Alchemist's latest batch puts AI to work as accelerator expands to Tokyo, Doha
TechCrunch· 3 日前Alchemist Accelerator has a new pile of AI-forward companies demoing their wares today, if you care to watch, and the program ...
神經幹細胞治療:治療帕金森病的創新路徑_科教文衛_中國網商務頻道
中國網· 4 日前專注神經幹細胞藥物開發的上海安集協康生物技術股份有限公司,歷時14年研發創新,致力於攻克神經幹細胞移植治療神經退行性疾病中的關鍵問題。